Optimapharm Lithuania UAB Finance - revenue, profit
EBITDA margin (%)
Enjoy unlimited use
with Freemium unlimitedEBIT margin (%)
Enjoy unlimited use
with Freemium unlimited| Indicator |
|---|
| Turnover (€) |
| Sales per employee (€) |
| Profit before tax (€) |
| Net Profit (€) |
| Profit per employee (€) |
| Total profitability (%) |
| Net profitability (%) |
| Equity (€) |
| Amounts Payable And Liabilities (€) |
| Non-current Assets (€) |
| CurrentAssets (€) |
| Working capital requirement |
| Debt-to-equity ratio |
| EBITDA margin (%) |
| EBITDA (€) |
| EBIT margin (%) |
| EBIT (€) |
| 2023 |
|---|
| 1,020,985 |
| 69,172 |
| 56,423 |
| 36,814 |
| 2,494 |
| 15.25 |
| 3.61 |
| 265,060 |
| 264,334 |
| 706 |
| 507,249 |
| 2024 |
|---|
| 952,307 |
| 66,502 |
| 60,287 |
| 50,440 |
| 3,522 |
| 16.16 |
| 5.30 |
| 315,500 |
| 263,016 |
| 706 |
| 364,790 |
| 2025 |
|---|
| 894,613 |
| 66,268 |
| 98,781 |
| 88,364 |
| 6,545 |
| 18.11 |
| 9.88 |
| 141,614 |
| 643,910 |
| 706 |
| 784,818 |
Enjoy unlimited use
with Freemium unlimited| 2025 |
|---|
| 894,613 |
| 66,268 |
| 98,781 |
| 88,364 |
| 6,545 |
| 18.11 |
| 9.88 |
| 141,614 |
| 643,910 |
| 706 |
| 784,818 |
Enjoy unlimited use
with Freemium unlimitedTurnover (€)
2025
Turnover (€)
894,613 €-6 % *
Sales per employee (€)
66,268 €0 % *
Profit before tax (€)
98,781 €64 % *
Net Profit (€)
88,364 €75 % *
Profit per employee (€)
6,545 €86 % *
Total profitability (%)
18.11 %12.07 % *
Net profitability (%)
9.88 %86.42 % *
Equity (€)
141,614 €-55 % *
Amounts Payable And Liabilities (€)
643,910 €145 % *
Non-current Assets (€)
706 €0 % *
CurrentAssets (€)
784,818 €115 % *
